Damora Therapeutics, Inc. GLTO
21.58 USD 0.00 (+0.00%)
Jun 4, 2026, 12:02 PM EDT
21.58 Day range 23.54
52-week range unavailable
- YTD
- -6.21%
- 1 year
- +659.86%
Latest period ending Dec 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -22.26M | -39.91M | -61.21M | -52.23M | -33.64M | |
| -21.44M | -38.35M | -61.62M | -51.75M | -34.84M | |
| -18.53 | -36.08 | -61.00 | -51.00 | -190.00 |
Balance sheet
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 14.18M | 21.46M | 32.79M | 62.56M | 163.84M | |
| 17.13M | 38.23M | 73.19M | 122.22M | 171.60M | |
| 1.30M | 5.90M | 11.44M | 4.99M | 6.11M | |
| 61.00K | 66.00K | 328.00K | 448.00K | 541.00K | |
| 15.83M | 32.33M | 61.75M | 117.22M | 165.49M |
Cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -18.62M | -36.91M | -42.93M | -52.31M | -38.20M | |
| 11.65M | 22.33M | 12.38M | -48.05M | 0 | |
| -6.97M | -11.71M | -30.04M | -100.36M | 149.19M |